logo-biolife.png
BIOLIFE4D Launches Second Regulation A+ (Mini-IPO) Offering Due to Popular Demand
September 06, 2019 07:30 ET | BIOLIFE4D
CHICAGO, Sept. 06, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its...
American Kidney Fund to Host CDC Million Hearts Collaboration Biannual Meeting, Spotlighting Connection Between Kidney Disease and Heart Disease
March 26, 2019 13:53 ET | American Kidney Fund
ROCKVILLE, Md., March 26, 2019 (GLOBE NEWSWIRE) -- As Kidney Month draws to a close, the American Kidney Fund (AKF) is hosting the March 27 biannual meeting of the Million Hearts® Collaboration,...
RND logo.PNG
Non-Alcoholic Steatohepatitis (NASH) Market To Reach USD 13.38 Billion By 2026 | Reports And Data
February 27, 2019 08:33 ET | Reports And Data
Increasing prevalence of obesity coupled with rising adoption of sedentary lifestyle is the major factor influencing market growth. Market Size – USD 0.41 billion in 2018, Market Growth - CAGR of...
New American Kidney Fund Survey Highlights Importance of Patient-Practitioner Discussions About Anemia
February 04, 2019 12:29 ET | American Kidney Fund
Rockville, MD, Feb. 04, 2019 (GLOBE NEWSWIRE) -- A new survey by the American Kidney Fund (AKF) shows gaps in patient awareness and understanding of anemia, a serious health condition that is a...
Picture1.png
BIOLIFE4D Appoints Management Advisory Board
January 28, 2019 08:30 ET | BIOLIFE4D Corporation
CHICAGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has established a...
Effective, High-quality Curcumin Enters Health Marketplace
July 05, 2018 11:27 ET | Nutent Therapeutics, Inc.
BOCA RATON, Fla., July 05, 2018 (GLOBE NEWSWIRE) -- The first highly purified and well-regulated pharmaceutical-grade curcumin, the most widely-studied plant-derived medicinal chemical in modern...
Picture1.png
BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue
June 25, 2018 08:00 ET | BIOLIFE4D Corporation
CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
Picture1.png
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Due to Popular Demand
June 23, 2018 08:00 ET | BIOLIFE4D Corporation
CHICAGO, June 23, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying...
Picture1.png
BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology
May 29, 2018 08:02 ET | BIOLIFE4D Corporation
CHICAGO, May 29, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is now a resident...
Minimally Invasive Investigational Procedure Treats Mitral Regurgitation as an Alternative to Open Heart Surgery
April 25, 2018 13:00 ET | UPMC Pinnacle
HARRISBURG, PA, April 25, 2018 (GLOBE NEWSWIRE) -- The ACTIVE trial studies Edwards Cardioband Mitral Reconstruction System, a catheter-based annular reduction device for treatment of functional...